(Q33818468)

29 July 2017

1 reference

title

Pathogenesis and treatment of juvenile onset recurrent respiratory papillomatosis (English)

1 reference

ORCID Public Data File 2021

29 July 2017

1 reference

author name string

Green GE

series ordinal

1

1 reference

29 July 2017

Bauman NM

series ordinal

2

1 reference

29 July 2017

Smith RJ

series ordinal

3

1 reference

29 July 2017

publication date

1 February 2000

1 reference

Otolaryngologic Clinics of North America

29 July 2017

published in

1 reference

29 July 2017

volume

33

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

187-207

1 reference

Laryngeal papillomatosis: clinical, histopathologic and molecular studies

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Recurrent respiratory papillomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

The use of cis-retinoic acid in recurrent respiratory papillomatosis of the larynx: a randomized pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Alpha-Interferon (Wellferon) as an Adjunct to Standard Surgical Therapy in the Management of Recurrent Respiratory Papillomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Task force on recurrent respiratory papillomas. A preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

A staging system for assessing severity of disease and response to therapy in recurrent respiratory papillomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Recurrent respiratory papillomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Changes in human papillomavirus typing of recurrent respiratory papillomatosis progressing to malignant neoplasm.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Isotretinoin therapy for recurrent respiratory papillomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Acyclovir in the treatment of recurrent respiratory papillomatosis. A pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Human papillomaviruses: general features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Therapy of human papillomavirus infection and associated epithelial tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Contribution to the etiology of laryngeal papilloma in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Treatment of recurrent respiratory papillomatosis with human leukocyte interferon. Results of a multicenter randomized clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Fetal maternal laryngeal papillomatosis in pregnancy:A case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Natural history of cervicovaginal papillomavirus infection in young women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Polymerase Chain Reaction Identification of Human Papillomavirus DNA in CO2 Laser Plume from Recurrent Respiratory Papillomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Sites of predilection in recurrent respiratory papillomatosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

A comparison of risk factors in juvenile‐onset and adult‐onset recurrent respiratory papillomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Acyclovir in the treatment of recurrent respiratory papillomatosis: a preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Long-term response of recurrent respiratory papillomatosis to treatment with lymphoblastoid interferon alfa-N1. Papilloma Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Laryngeal papillomas: the epidemiology in a Danish subpopulation 1965-1984.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

13-Cis-retinoic acid plus interferon-alpha 2a in recurrent respiratory papillomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Acyclovir in the treatment of laryngeal papillomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Interferon and laryngeal papillomatosis. The Iowa experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Pilot trial of ribavirin for the treatment of laryngeal papillomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Juvenile respiratory papillomatosis: acyclovir reassessed

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Clinical effects of alpha-interferon dose variation on laryngeal papillomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Soft-tissue complications of laser surgery for recurrent respiratory papillomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Relationship between the clinical course and HPV typing of recurrent laryngeal papillomatosis. The Red Cross War Memorial Children's Hospital experience 1982-1988

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Detection of Human Papillomavirus Infection in Diseased and Nondiseased Sites of the Respiratory Tract in Recurrent Respiratory Papillomatosis Patients by DNA Hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Adult respiratory papillomatosis: human papillomavirus type and viral coinfections as predictors of prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Exposure of an infant to cervical human papillomavirus infection of the mother is common

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Malignant transformation of recurrent respiratory papillomatosis associated with integrated human papillomavirus type 11 DNA and mutation of p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Pediatric respiratory papillomatosis: prognostic role of viral typing and cofactors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Preliminary results of the use of indole-3-carbinol for recurrent respiratory papillomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Further Observations on the Treatment of Recurrent Respiratory Papillomatosis with Interferon: A Comparison of Sources

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Risk factors for juvenile onset recurrent respiratory papillomatosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Efficacy of DHE photodynamic therapy for respiratory papillomatosis: immediate and long-term results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Malignant transformation in non-irradiated recurrent respiratory papillomatosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Persistence and expression of human papillomavirus during interferon therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Recurrent respiratory papillomatosis: management with the CO2 laser

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

Tracheal involvement in laryngeal papillomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2805%2970215-2

10.1016/S0030-6665(05)70215-2

7 January 2021

Identifiers

DOI

1 reference

29 July 2017

1 reference